Very high-power short-duration temperature-controlled ablation versus conventional power-controlled ablation for pulmonary vein isolation: The fast and furious - AF study

Background: Catheter ablation for atrial fibrillation (AF) treatment provides effective and durable pulmonary vein isolation (PVI) and is associated with encouraging clinical outcome. A novel CF sensing temperature-controlled radiofrequency (RF) ablation catheter allows for very high-power short-dur...

Full description

Bibliographic Details
Main Authors: Roland Richard Tilz, Makoto Sano, Julia Vogler, Thomas Fink, Roza Saraei, Vanessa Sciacca, Bettina Kirstein, Huong-Lan Phan, Sascha Hatahet, Lisbeth Delgado Lopez, Anna Traub, Charlotte Eitel, Michael Schlüter, Karl-Heinz Kuck, Christian-Hendrik Heeger
Format: Article
Language:English
Published: Elsevier 2021-08-01
Series:International Journal of Cardiology: Heart & Vasculature
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2352906721001354
_version_ 1818600062931959808
author Roland Richard Tilz
Makoto Sano
Julia Vogler
Thomas Fink
Roza Saraei
Vanessa Sciacca
Bettina Kirstein
Huong-Lan Phan
Sascha Hatahet
Lisbeth Delgado Lopez
Anna Traub
Charlotte Eitel
Michael Schlüter
Karl-Heinz Kuck
Christian-Hendrik Heeger
author_facet Roland Richard Tilz
Makoto Sano
Julia Vogler
Thomas Fink
Roza Saraei
Vanessa Sciacca
Bettina Kirstein
Huong-Lan Phan
Sascha Hatahet
Lisbeth Delgado Lopez
Anna Traub
Charlotte Eitel
Michael Schlüter
Karl-Heinz Kuck
Christian-Hendrik Heeger
author_sort Roland Richard Tilz
collection DOAJ
description Background: Catheter ablation for atrial fibrillation (AF) treatment provides effective and durable pulmonary vein isolation (PVI) and is associated with encouraging clinical outcome. A novel CF sensing temperature-controlled radiofrequency (RF) ablation catheter allows for very high-power short-duration (vHP-SD, 90 W/4 s) ablation aiming a potentially safer, more effective and faster ablation. We thought to evaluate preliminary safety and efficacy of vHP-SD ablation for PVI utilizing a novel vHP-SD catheter. The data was compared to conventional power-controlled ablation index (AI) guided PVI utilizing conventional contact force (CF) sensing catheters. Methods and Results: Fifty-six patients with paroxysmal or persistent AF were prospectively enrolled in this study. Twenty-eight consecutive patients underwent vHP-SD based PVI (vHP-SD group) and were compared to 28 consecutive patients treated with conventional CF-sensing catheters utilizing the AI (control group). All PVs were successfully isolated using vHP-SD. The median RF ablation time for vHP-SD was 338 (IQR 286, 367) seconds vs control 1580 (IQR 1350, 1848) seconds (p < 0.0001), the median procedure duration was vHP-SD 55 (IQR 48–60) minutes vs. control 105 (IQR 92–120) minutes (p < 0.0001). No differences in periprocedural complications were observed. Conclusions: This preliminary data of the novel vHP-SD ablation mode provides safe and effective PVI. Procedure duration and RF ablation time were substantially shorter in the vHP-SD group in comparison to the control group.
first_indexed 2024-12-16T12:29:31Z
format Article
id doaj.art-172679b45f994151b86e031ee3a227d5
institution Directory Open Access Journal
issn 2352-9067
language English
last_indexed 2024-12-16T12:29:31Z
publishDate 2021-08-01
publisher Elsevier
record_format Article
series International Journal of Cardiology: Heart & Vasculature
spelling doaj.art-172679b45f994151b86e031ee3a227d52022-12-21T22:31:43ZengElsevierInternational Journal of Cardiology: Heart & Vasculature2352-90672021-08-0135100847Very high-power short-duration temperature-controlled ablation versus conventional power-controlled ablation for pulmonary vein isolation: The fast and furious - AF studyRoland Richard Tilz0Makoto Sano1Julia Vogler2Thomas Fink3Roza Saraei4Vanessa Sciacca5Bettina Kirstein6Huong-Lan Phan7Sascha Hatahet8Lisbeth Delgado Lopez9Anna Traub10Charlotte Eitel11Michael Schlüter12Karl-Heinz Kuck13Christian-Hendrik Heeger14University Heart Center Lübeck, Division of Electrophysiology, Medical Clinic II (Department of Cardiology, Angiology and Intensive Care Medicine), University Hospital Schleswig-Holstein, Germany; German Center for Cardiovascular Research (DZHK), Partner Site Hamburg/Kiel/Lübeck, Lübeck, Germany; Corresponding authors at: Division of Electrophysiology, Medizinische Klinik II (Kardiologie Angiologie, Intensivmedizin), Universitäres Herzzentrum Lübeck, Universitätsklinikum Schleswig-Holstein (UKSH), Ratzeburger Allee 160, Lübeck D-23538, Germany.University Heart Center Lübeck, Division of Electrophysiology, Medical Clinic II (Department of Cardiology, Angiology and Intensive Care Medicine), University Hospital Schleswig-Holstein, Germany; Division of Cardiology, Internal Medicine III, Hamamatsu University School of Medicine, Hamamatsu, JapanUniversity Heart Center Lübeck, Division of Electrophysiology, Medical Clinic II (Department of Cardiology, Angiology and Intensive Care Medicine), University Hospital Schleswig-Holstein, GermanyUniversity Heart Center Lübeck, Division of Electrophysiology, Medical Clinic II (Department of Cardiology, Angiology and Intensive Care Medicine), University Hospital Schleswig-Holstein, GermanyUniversity Heart Center Lübeck, Division of Electrophysiology, Medical Clinic II (Department of Cardiology, Angiology and Intensive Care Medicine), University Hospital Schleswig-Holstein, GermanyUniversity Heart Center Lübeck, Division of Electrophysiology, Medical Clinic II (Department of Cardiology, Angiology and Intensive Care Medicine), University Hospital Schleswig-Holstein, GermanyUniversity Heart Center Lübeck, Division of Electrophysiology, Medical Clinic II (Department of Cardiology, Angiology and Intensive Care Medicine), University Hospital Schleswig-Holstein, GermanyUniversity Heart Center Lübeck, Division of Electrophysiology, Medical Clinic II (Department of Cardiology, Angiology and Intensive Care Medicine), University Hospital Schleswig-Holstein, GermanyUniversity Heart Center Lübeck, Division of Electrophysiology, Medical Clinic II (Department of Cardiology, Angiology and Intensive Care Medicine), University Hospital Schleswig-Holstein, GermanyUniversity Heart Center Lübeck, Division of Electrophysiology, Medical Clinic II (Department of Cardiology, Angiology and Intensive Care Medicine), University Hospital Schleswig-Holstein, GermanyUniversity Heart Center Lübeck, Division of Electrophysiology, Medical Clinic II (Department of Cardiology, Angiology and Intensive Care Medicine), University Hospital Schleswig-Holstein, GermanyUniversity Heart Center Lübeck, Division of Electrophysiology, Medical Clinic II (Department of Cardiology, Angiology and Intensive Care Medicine), University Hospital Schleswig-Holstein, GermanyLANS Cardio, Stephansplatz 5, Hamburg 20354, GermanyUniversity Heart Center Lübeck, Division of Electrophysiology, Medical Clinic II (Department of Cardiology, Angiology and Intensive Care Medicine), University Hospital Schleswig-Holstein, Germany; LANS Cardio, Stephansplatz 5, Hamburg 20354, GermanyUniversity Heart Center Lübeck, Division of Electrophysiology, Medical Clinic II (Department of Cardiology, Angiology and Intensive Care Medicine), University Hospital Schleswig-Holstein, Germany; German Center for Cardiovascular Research (DZHK), Partner Site Hamburg/Kiel/Lübeck, Lübeck, Germany; Corresponding authors at: Division of Electrophysiology, Medizinische Klinik II (Kardiologie Angiologie, Intensivmedizin), Universitäres Herzzentrum Lübeck, Universitätsklinikum Schleswig-Holstein (UKSH), Ratzeburger Allee 160, Lübeck D-23538, Germany.Background: Catheter ablation for atrial fibrillation (AF) treatment provides effective and durable pulmonary vein isolation (PVI) and is associated with encouraging clinical outcome. A novel CF sensing temperature-controlled radiofrequency (RF) ablation catheter allows for very high-power short-duration (vHP-SD, 90 W/4 s) ablation aiming a potentially safer, more effective and faster ablation. We thought to evaluate preliminary safety and efficacy of vHP-SD ablation for PVI utilizing a novel vHP-SD catheter. The data was compared to conventional power-controlled ablation index (AI) guided PVI utilizing conventional contact force (CF) sensing catheters. Methods and Results: Fifty-six patients with paroxysmal or persistent AF were prospectively enrolled in this study. Twenty-eight consecutive patients underwent vHP-SD based PVI (vHP-SD group) and were compared to 28 consecutive patients treated with conventional CF-sensing catheters utilizing the AI (control group). All PVs were successfully isolated using vHP-SD. The median RF ablation time for vHP-SD was 338 (IQR 286, 367) seconds vs control 1580 (IQR 1350, 1848) seconds (p < 0.0001), the median procedure duration was vHP-SD 55 (IQR 48–60) minutes vs. control 105 (IQR 92–120) minutes (p < 0.0001). No differences in periprocedural complications were observed. Conclusions: This preliminary data of the novel vHP-SD ablation mode provides safe and effective PVI. Procedure duration and RF ablation time were substantially shorter in the vHP-SD group in comparison to the control group.http://www.sciencedirect.com/science/article/pii/S2352906721001354Atrial fibrillationHigh-power short duration, pulmonary vein isolationRadiofrequencyAcute efficacy
spellingShingle Roland Richard Tilz
Makoto Sano
Julia Vogler
Thomas Fink
Roza Saraei
Vanessa Sciacca
Bettina Kirstein
Huong-Lan Phan
Sascha Hatahet
Lisbeth Delgado Lopez
Anna Traub
Charlotte Eitel
Michael Schlüter
Karl-Heinz Kuck
Christian-Hendrik Heeger
Very high-power short-duration temperature-controlled ablation versus conventional power-controlled ablation for pulmonary vein isolation: The fast and furious - AF study
International Journal of Cardiology: Heart & Vasculature
Atrial fibrillation
High-power short duration, pulmonary vein isolation
Radiofrequency
Acute efficacy
title Very high-power short-duration temperature-controlled ablation versus conventional power-controlled ablation for pulmonary vein isolation: The fast and furious - AF study
title_full Very high-power short-duration temperature-controlled ablation versus conventional power-controlled ablation for pulmonary vein isolation: The fast and furious - AF study
title_fullStr Very high-power short-duration temperature-controlled ablation versus conventional power-controlled ablation for pulmonary vein isolation: The fast and furious - AF study
title_full_unstemmed Very high-power short-duration temperature-controlled ablation versus conventional power-controlled ablation for pulmonary vein isolation: The fast and furious - AF study
title_short Very high-power short-duration temperature-controlled ablation versus conventional power-controlled ablation for pulmonary vein isolation: The fast and furious - AF study
title_sort very high power short duration temperature controlled ablation versus conventional power controlled ablation for pulmonary vein isolation the fast and furious af study
topic Atrial fibrillation
High-power short duration, pulmonary vein isolation
Radiofrequency
Acute efficacy
url http://www.sciencedirect.com/science/article/pii/S2352906721001354
work_keys_str_mv AT rolandrichardtilz veryhighpowershortdurationtemperaturecontrolledablationversusconventionalpowercontrolledablationforpulmonaryveinisolationthefastandfuriousafstudy
AT makotosano veryhighpowershortdurationtemperaturecontrolledablationversusconventionalpowercontrolledablationforpulmonaryveinisolationthefastandfuriousafstudy
AT juliavogler veryhighpowershortdurationtemperaturecontrolledablationversusconventionalpowercontrolledablationforpulmonaryveinisolationthefastandfuriousafstudy
AT thomasfink veryhighpowershortdurationtemperaturecontrolledablationversusconventionalpowercontrolledablationforpulmonaryveinisolationthefastandfuriousafstudy
AT rozasaraei veryhighpowershortdurationtemperaturecontrolledablationversusconventionalpowercontrolledablationforpulmonaryveinisolationthefastandfuriousafstudy
AT vanessasciacca veryhighpowershortdurationtemperaturecontrolledablationversusconventionalpowercontrolledablationforpulmonaryveinisolationthefastandfuriousafstudy
AT bettinakirstein veryhighpowershortdurationtemperaturecontrolledablationversusconventionalpowercontrolledablationforpulmonaryveinisolationthefastandfuriousafstudy
AT huonglanphan veryhighpowershortdurationtemperaturecontrolledablationversusconventionalpowercontrolledablationforpulmonaryveinisolationthefastandfuriousafstudy
AT saschahatahet veryhighpowershortdurationtemperaturecontrolledablationversusconventionalpowercontrolledablationforpulmonaryveinisolationthefastandfuriousafstudy
AT lisbethdelgadolopez veryhighpowershortdurationtemperaturecontrolledablationversusconventionalpowercontrolledablationforpulmonaryveinisolationthefastandfuriousafstudy
AT annatraub veryhighpowershortdurationtemperaturecontrolledablationversusconventionalpowercontrolledablationforpulmonaryveinisolationthefastandfuriousafstudy
AT charlotteeitel veryhighpowershortdurationtemperaturecontrolledablationversusconventionalpowercontrolledablationforpulmonaryveinisolationthefastandfuriousafstudy
AT michaelschluter veryhighpowershortdurationtemperaturecontrolledablationversusconventionalpowercontrolledablationforpulmonaryveinisolationthefastandfuriousafstudy
AT karlheinzkuck veryhighpowershortdurationtemperaturecontrolledablationversusconventionalpowercontrolledablationforpulmonaryveinisolationthefastandfuriousafstudy
AT christianhendrikheeger veryhighpowershortdurationtemperaturecontrolledablationversusconventionalpowercontrolledablationforpulmonaryveinisolationthefastandfuriousafstudy